Clinical Trial Update: OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients

View source ↗

Summary

A clinical trial update indicates a study evaluating optimized miltefosine treatment for cutaneous leishmaniasis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Impavido (miltefosine)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Cutaneous Leishmaniases | Status: RECRUITING